| |
| |
|
| Insider
Information: |
Rakin Kevin |
| Relationship: |
|
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
522,967 |
|
|
Indirect Shares
|
7,152,757 |
|
|
| Direct
Value |
$215,215 |
|
|
|
Indirect Value
|
$2,249,771 |
|
|
| Total
Shares |
7,675,724 |
|
|
| Total
Value |
$2,464,986 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -81.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director |
2006-11-20 |
29,926 |
2006-11-20 |
6,500 |
Premium* |
|
|
Vion Pharmaceuticals Inc |
VIONQ |
Director |
2008-12-11 |
7,229 |
2007-01-15 |
0 |
Premium* |
|
|
Ocugen Ord Shs |
OCGN |
Director |
2019-02-08 |
418,639 |
2019-02-08 |
257,846 |
Premium* |
|
|
Oramed Pharmaceuticals Inc |
ORMP |
Director |
2022-03-21 |
46,661 |
2016-12-01 |
0 |
Premium* |
|
|
Aziyo Biologics, Inc. |
AZYO |
Director, 10% Owner |
|
0 |
2022-12-05 |
5,688,411 |
Premium* |
|
|
Highcape Capital Acquisition Corp. |
QSI |
|
2022-12-20 |
20,512 |
2022-12-20 |
1,200,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QSI |
Highcape Capital Acquisit... |
|
• • – |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(601,000) |
1,200,000 |
0 |
- |
|
| QSI |
Highcape Capital Acquisit... |
|
• • – |
2022-12-15 |
4 |
S |
$2.15 |
$191,234 |
I/I |
(89,000) |
1,801,000 |
0 |
% |
|
| AZYO |
Aziyo Biologics, Inc. |
Director |
– • • |
2022-12-05 |
4 |
B |
$4.75 |
$3,491,250 |
I/I |
735,000 |
5,597,604 |
2.25 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2022-03-21 |
4 |
S |
$9.41 |
$94,096 |
D/D |
(10,000) |
46,661 |
0 |
% |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2022-02-17 |
4 |
D |
$10.63 |
$31,996 |
D/D |
(3,010) |
56,661 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2022-02-17 |
4 |
OE |
$4.80 |
$32,002 |
D/D |
6,667 |
59,671 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2022-02-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
47,004 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2022-02-11 |
4/A |
GD |
$0.00 |
$0 |
D/D |
5,000 |
53,004 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
58,004 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2021-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
52,004 |
0 |
- |
|
| AZYO |
Aziyo Biologics, Inc. |
Director |
– • • |
2021-12-08 |
4 |
B |
$4.24 |
$1,749,996 |
I/I |
412,735 |
90,807 |
2.25 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2021-09-16 |
4 |
S |
$20.99 |
$442,830 |
D/D |
(21,100) |
57,004 |
0 |
% |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
78,104 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2021-08-09 |
4 |
OE |
$4.17 |
$550,315 |
D/D |
79,136 |
89,020 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2021-08-09 |
4 |
D |
$21.09 |
$550,301 |
D/D |
(26,093) |
68,104 |
0 |
- |
|
| QSI |
Highcape Capital Acquisit... |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
20,512 |
20,512 |
0 |
- |
|
| QSI |
Highcape Capital Acquisit... |
Director |
– • – |
2021-06-10 |
4 |
A |
$10.00 |
$19,010,000 |
I/I |
1,901,000 |
1,901,000 |
0 |
- |
|
| AZYO |
Aziyo Biologics, Inc. |
Director |
– • • |
2020-10-13 |
4 |
B |
$17.00 |
$7,499,992 |
I/I |
441,176 |
4,508,831 |
2.25 |
- |
|
| AZYO |
Aziyo Biologics, Inc. |
Director |
– • • |
2020-10-13 |
4 |
D |
$5.44 |
$13,339 |
I/I |
(2,451) |
4,067,655 |
0 |
- |
|
| AZYO |
Aziyo Biologics, Inc. |
Director |
– • • |
2020-10-13 |
4 |
OE |
$5.44 |
$41,662 |
I/I |
7,655 |
4,070,106 |
0 |
- |
|
| AZYO |
Aziyo Biologics, Inc. |
Director |
– • • |
2020-10-13 |
4 |
A |
$0.00 |
$0 |
I/I |
4,062,451 |
4,062,451 |
0 |
- |
|
| AZYO |
Aziyo Biologics, Inc. |
Director |
– • • |
2020-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,845 |
|
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
173,076 |
418,639 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
177,777 |
257,846 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2018-10-10 |
4 |
B |
$0.00 |
$0 |
D/D |
230,768 |
245,563 |
2.31 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
